Novartis Lowers Price On Allergy Drug

The price on Atopica has been reduced by Novartis.

Novartis Animal Health has reduced the price by up to 34 percent on its Atopica (Cyclosporine capsules, USP) Modified, a nonsteroidal oral therapy developed to control canine atopic dermatitis.

"Atopic dermatitis is an expensive disease to treat," said John Rehak, DVM, Atopica senior product manager. "By passing the new cost savings along to their clients, veterinarians will be able to help more patients suffering from the relentless misery caused by atopy. Comfortable dogs mean satisfied, happy and loyal clients, which makes for a healthier clinic, too."

The new pricing, which covers all product sizes, will take effect Feb. 1.


Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.